Annual CAPEX
$3.91 B
+$671.00 M+20.74%
31 December 2023
Summary:
Pfizer annual capital expenditures is currently $3.91 billion, with the most recent change of +$671.00 million (+20.74%) on 31 December 2023. During the last 3 years, it has risen by +$1.68 billion (+75.52%). PFE annual CAPEX is now at all-time high.PFE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$651.00 M
+$14.00 M+2.20%
30 September 2024
Summary:
Pfizer quarterly capital expenditures is currently $651.00 million, with the most recent change of +$14.00 million (+2.20%) on 30 September 2024. Over the past year, it has dropped by -$159.00 million (-19.63%). PFE quarterly CAPEX is now -42.84% below its all-time high of $1.14 billion, reached on 31 March 2023.PFE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$3.04 B
-$159.00 M-4.98%
30 September 2024
Summary:
Pfizer TTM capital expenditures is currently $3.04 billion, with the most recent change of -$159.00 million (-4.98%) on 30 September 2024. Over the past year, it has dropped by -$828.00 million (-21.43%). PFE TTM CAPEX is now -22.29% below its all-time high of $3.91 billion, reached on 31 December 2023.PFE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | -19.6% | -21.4% |
| 3 y3 years | +75.5% | +5.3% | +20.4% |
| 5 y5 years | +82.9% | -1.7% | +16.8% |
PFE CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +75.5% | -42.8% | +5.3% | -22.3% | +20.4% |
| 5 y | 5 years | at high | +91.0% | -42.8% | +265.7% | -22.3% | +90.8% |
| alltime | all time | at high | +755.9% | -42.8% | +532.6% | -22.3% | +2850.4% |
Pfizer CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $651.00 M(+2.2%) | $3.04 B(-5.0%) |
| June 2024 | - | $637.00 M(-9.5%) | $3.19 B(-8.0%) |
| Mar 2024 | - | $704.00 M(-32.6%) | $3.47 B(-11.1%) |
| Dec 2023 | $3.91 B(+20.7%) | $1.04 B(+28.9%) | $3.91 B(+1.1%) |
| Sept 2023 | - | $810.00 M(-11.4%) | $3.86 B(-0.8%) |
| June 2023 | - | $914.00 M(-19.8%) | $3.90 B(+4.4%) |
| Mar 2023 | - | $1.14 B(+13.8%) | $3.73 B(+15.3%) |
| Dec 2022 | $3.24 B(+19.4%) | $1.00 B(+19.0%) | $3.24 B(-0.0%) |
| Sept 2022 | - | $841.00 M(+12.0%) | $3.24 B(+7.4%) |
| June 2022 | - | $751.00 M(+16.8%) | $3.01 B(+7.6%) |
| Mar 2022 | - | $643.00 M(-35.8%) | $2.80 B(+3.3%) |
| Dec 2021 | $2.71 B(+21.8%) | $1.00 B(+62.1%) | $2.71 B(+7.5%) |
| Sept 2021 | - | $618.00 M(+15.1%) | $2.52 B(+4.6%) |
| June 2021 | - | $537.00 M(-3.1%) | $2.41 B(+3.4%) |
| Mar 2021 | - | $554.00 M(-31.9%) | $2.33 B(+4.7%) |
| Dec 2020 | $2.23 B(+8.8%) | $813.00 M(+60.4%) | $2.23 B(+39.9%) |
| Sept 2020 | - | $507.00 M(+10.9%) | $1.59 B(-8.9%) |
| June 2020 | - | $457.00 M(+1.8%) | $1.75 B(-7.0%) |
| Mar 2020 | - | $449.00 M(+152.2%) | $1.88 B(-8.3%) |
| Dec 2019 | $2.05 B(-4.2%) | $178.00 M(-73.1%) | $2.05 B(-21.3%) |
| Sept 2019 | - | $662.00 M(+12.6%) | $2.60 B(+4.0%) |
| June 2019 | - | $588.00 M(-4.9%) | $2.50 B(+7.0%) |
| Mar 2019 | - | $618.00 M(-15.6%) | $2.34 B(+9.4%) |
| Dec 2018 | $2.14 B(-3.7%) | $732.00 M(+30.2%) | $2.14 B(-1.9%) |
| Sept 2018 | - | $562.00 M(+32.5%) | $2.18 B(-1.6%) |
| June 2018 | - | $424.00 M(+1.4%) | $2.21 B(-2.9%) |
| Mar 2018 | - | $418.00 M(-45.9%) | $2.28 B(+2.7%) |
| Dec 2017 | $2.22 B(+10.9%) | $773.00 M(+29.5%) | $2.22 B(+0.2%) |
| Sept 2017 | - | $597.00 M(+22.1%) | $2.21 B(+8.1%) |
| June 2017 | - | $489.00 M(+36.6%) | $2.05 B(-0.4%) |
| Mar 2017 | - | $358.00 M(-53.4%) | $2.06 B(+2.9%) |
| Dec 2016 | $2.00 B(+33.6%) | $769.00 M(+78.0%) | $2.00 B(+5.7%) |
| Sept 2016 | - | $432.00 M(-13.1%) | $1.89 B(+6.0%) |
| June 2016 | - | $497.00 M(+65.1%) | $1.78 B(+15.1%) |
| Mar 2016 | - | $301.00 M(-54.5%) | $1.55 B(+3.7%) |
| Dec 2015 | $1.50 B(-5.5%) | $662.00 M(+103.7%) | $1.50 B(+21.6%) |
| Sept 2015 | - | $325.00 M(+23.6%) | $1.23 B(-16.1%) |
| June 2015 | - | $263.00 M(+6.9%) | $1.47 B(-4.2%) |
| Mar 2015 | - | $246.00 M(-37.9%) | $1.53 B(-3.3%) |
| Dec 2014 | $1.58 B(+8.1%) | $396.00 M(-29.4%) | $1.58 B(-6.1%) |
| Sept 2014 | - | $561.00 M(+71.0%) | $1.69 B(+16.0%) |
| June 2014 | - | $328.00 M(+10.1%) | $1.45 B(+1.3%) |
| Mar 2014 | - | $298.00 M(-40.3%) | $1.44 B(-2.0%) |
| Dec 2013 | $1.47 B(+3.2%) | $499.00 M(+52.1%) | $1.47 B(-5.6%) |
| Sept 2013 | - | $328.00 M(+5.8%) | $1.55 B(+2.8%) |
| June 2013 | - | $310.00 M(-5.5%) | $1.51 B(+1.1%) |
| Mar 2013 | - | $328.00 M(-44.0%) | $1.49 B(+5.2%) |
| Dec 2012 | $1.42 B(-24.6%) | $586.00 M(+105.6%) | $1.42 B(-14.2%) |
| Sept 2012 | - | $285.00 M(-3.1%) | $1.65 B(-9.3%) |
| June 2012 | - | $294.00 M(+15.7%) | $1.82 B(-3.4%) |
| Mar 2012 | - | $254.00 M(-69.0%) | $1.89 B(+0.2%) |
| Dec 2011 | $1.88 B(+24.4%) | $820.00 M(+80.6%) | $1.88 B(+17.0%) |
| Sept 2011 | - | $454.00 M(+26.8%) | $1.61 B(+11.5%) |
| June 2011 | - | $358.00 M(+43.2%) | $1.44 B(-1.0%) |
| Mar 2011 | - | $250.00 M(-54.3%) | $1.46 B(-3.6%) |
| Dec 2010 | $1.51 B(+25.6%) | $547.00 M(+89.9%) | $1.51 B(+9.0%) |
| Sept 2010 | - | $288.00 M(-22.8%) | $1.39 B(+2.0%) |
| June 2010 | - | $373.00 M(+22.3%) | $1.36 B(+8.3%) |
| Mar 2010 | - | $305.00 M(-27.7%) | $1.26 B(+4.3%) |
| Dec 2009 | $1.21 B(-29.2%) | $422.00 M(+61.7%) | $1.21 B(+2.8%) |
| Sept 2009 | - | $261.00 M(-3.0%) | $1.17 B(-13.5%) |
| June 2009 | - | $269.00 M(+6.3%) | $1.35 B(-7.9%) |
| Mar 2009 | - | $253.00 M(-35.0%) | $1.47 B(-13.5%) |
| Dec 2008 | $1.70 B(-14.6%) | $389.00 M(-12.4%) | $1.70 B(-18.4%) |
| Sept 2008 | - | $444.00 M(+15.3%) | $2.08 B(-0.8%) |
| June 2008 | - | $385.00 M(-20.3%) | $2.10 B(-2.0%) |
| Mar 2008 | - | $483.00 M(-37.5%) | $2.15 B(+7.7%) |
| Dec 2007 | $1.99 B | $773.00 M(+67.7%) | $1.99 B(+0.4%) |
| Sept 2007 | - | $461.00 M(+7.7%) | $1.98 B(-4.3%) |
| June 2007 | - | $428.00 M(+30.1%) | $2.07 B(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $329.00 M(-57.0%) | $2.11 B(-4.0%) |
| Dec 2006 | $2.20 B(+4.6%) | $765.00 M(+38.8%) | $2.20 B(+7.4%) |
| Sept 2006 | - | $551.00 M(+17.5%) | $2.05 B(+2.8%) |
| June 2006 | - | $469.00 M(+12.2%) | $2.00 B(-3.1%) |
| Mar 2006 | - | $418.00 M(-31.8%) | $2.06 B(-2.2%) |
| Dec 2005 | $2.11 B(-19.0%) | $613.00 M(+23.6%) | $2.11 B(-18.0%) |
| Sept 2005 | - | $496.00 M(-6.8%) | $2.57 B(-2.6%) |
| June 2005 | - | $532.00 M(+14.4%) | $2.64 B(+1.7%) |
| Mar 2005 | - | $465.00 M(-56.7%) | $2.59 B(-0.3%) |
| Dec 2004 | $2.60 B(-1.1%) | $1.07 B(+90.3%) | $2.60 B(+13.4%) |
| Sept 2004 | - | $565.00 M(+15.5%) | $2.29 B(-3.9%) |
| June 2004 | - | $489.00 M(+3.6%) | $2.39 B(-12.2%) |
| Mar 2004 | - | $472.00 M(-38.5%) | $2.72 B(+3.4%) |
| Dec 2003 | $2.63 B(+49.5%) | $767.00 M(+16.6%) | $2.63 B(+7.4%) |
| Sept 2003 | - | $658.00 M(-20.0%) | $2.45 B(+13.3%) |
| June 2003 | - | $822.00 M(+115.2%) | $2.16 B(+22.0%) |
| Mar 2003 | - | $382.00 M(-34.8%) | $1.77 B(+0.7%) |
| Dec 2002 | $1.76 B(-16.5%) | $586.00 M(+58.0%) | $1.76 B(0.0%) |
| Sept 2002 | - | $371.00 M(-14.1%) | $1.76 B(-8.8%) |
| June 2002 | - | $432.00 M(+17.1%) | $1.93 B(-5.7%) |
| Mar 2002 | - | $369.00 M(-37.0%) | $2.04 B(-2.9%) |
| Dec 2001 | $2.10 B(-3.9%) | $586.00 M(+8.5%) | $2.10 B(+3.0%) |
| Sept 2001 | - | $540.00 M(-1.6%) | $2.04 B(-3.9%) |
| June 2001 | - | $549.00 M(+27.7%) | $2.13 B(-1.8%) |
| Mar 2001 | - | $430.00 M(-17.9%) | $2.17 B(-1.1%) |
| Dec 2000 | $2.19 B(-12.1%) | $524.00 M(-16.0%) | $2.19 B(+3.2%) |
| Sept 2000 | - | $624.00 M(+5.9%) | $2.12 B(-12.7%) |
| June 2000 | - | $589.00 M(+29.7%) | $2.43 B(-6.2%) |
| Mar 2000 | - | $454.00 M(-0.7%) | $2.60 B(+4.1%) |
| Dec 1999 | $2.49 B(+27.8%) | $457.00 M(-51.0%) | $2.49 B(-21.5%) |
| Sept 1999 | - | $933.00 M(+24.2%) | $3.17 B(+22.4%) |
| June 1999 | - | $751.00 M(+113.4%) | $2.59 B(+22.7%) |
| Mar 1999 | - | $352.00 M(-69.1%) | $2.11 B(+8.3%) |
| Dec 1998 | $1.95 B(+122.2%) | $1.14 B(+223.3%) | $1.95 B(+79.5%) |
| Sept 1998 | - | $352.00 M(+29.9%) | $1.09 B(+18.3%) |
| June 1998 | - | $271.00 M(+42.6%) | $919.00 M(+7.2%) |
| Mar 1998 | - | $190.00 M(-30.7%) | $857.00 M(-2.4%) |
| Dec 1997 | $878.00 M(-23.0%) | $274.00 M(+48.9%) | $878.00 M(-28.9%) |
| Sept 1997 | - | $184.00 M(-12.0%) | $1.24 B(-1.0%) |
| June 1997 | - | $209.00 M(-0.9%) | $1.25 B(+2.5%) |
| Mar 1997 | - | $211.00 M(-66.6%) | $1.22 B(+6.7%) |
| Dec 1996 | $1.14 B(+63.9%) | $631.00 M(+220.3%) | $1.14 B(+60.0%) |
| Sept 1996 | - | $197.00 M(+10.7%) | $713.10 M(+2.8%) |
| June 1996 | - | $178.00 M(+31.9%) | $693.60 M(+9.2%) |
| Mar 1996 | - | $135.00 M(-33.5%) | $634.90 M(-8.8%) |
| Dec 1995 | $696.30 M(+3.7%) | $203.10 M(+14.4%) | $696.30 M(+1.4%) |
| Sept 1995 | - | $177.50 M(+48.8%) | $686.90 M(-1.6%) |
| June 1995 | - | $119.30 M(-39.3%) | $698.10 M(-5.6%) |
| Mar 1995 | - | $196.40 M(+1.4%) | $739.70 M(+10.2%) |
| Dec 1994 | $671.50 M(+5.9%) | $193.70 M(+2.6%) | $671.50 M(-1.5%) |
| Sept 1994 | - | $188.70 M(+17.3%) | $681.50 M(+7.1%) |
| June 1994 | - | $160.90 M(+25.5%) | $636.60 M(+0.6%) |
| Mar 1994 | - | $128.20 M(-37.1%) | $632.60 M(-0.3%) |
| Dec 1993 | $634.20 M(-5.9%) | $203.70 M(+41.7%) | $634.20 M(-2.8%) |
| Sept 1993 | - | $143.80 M(-8.3%) | $652.60 M(-4.7%) |
| June 1993 | - | $156.90 M(+20.9%) | $685.10 M(+0.9%) |
| Mar 1993 | - | $129.80 M(-41.6%) | $679.00 M(+0.7%) |
| Dec 1992 | $674.20 M(+13.5%) | $222.10 M(+26.0%) | $674.20 M(+5.7%) |
| Sept 1992 | - | $176.30 M(+16.9%) | $637.60 M(+3.9%) |
| June 1992 | - | $150.80 M(+20.6%) | $613.70 M(+1.8%) |
| Mar 1992 | - | $125.00 M(-32.6%) | $602.90 M(+1.5%) |
| Dec 1991 | $593.80 M(+8.5%) | $185.50 M(+21.7%) | $593.80 M(+5.5%) |
| Sept 1991 | - | $152.40 M(+8.9%) | $562.90 M(-0.2%) |
| June 1991 | - | $140.00 M(+20.8%) | $564.00 M(+0.6%) |
| Mar 1991 | - | $115.90 M(-25.0%) | $560.50 M(+2.4%) |
| Dec 1990 | $547.50 M(+19.9%) | $154.60 M(+0.7%) | $547.50 M(+39.3%) |
| Sept 1990 | - | $153.50 M(+12.5%) | $392.90 M(+64.1%) |
| June 1990 | - | $136.50 M(+32.7%) | $239.40 M(+132.7%) |
| Mar 1990 | - | $102.90 M | $102.90 M |
| Dec 1989 | $456.50 M | - | - |
FAQ
- What is Pfizer annual capital expenditures?
- What is the all time high annual CAPEX for Pfizer?
- What is Pfizer annual CAPEX year-on-year change?
- What is Pfizer quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Pfizer?
- What is Pfizer quarterly CAPEX year-on-year change?
- What is Pfizer TTM capital expenditures?
- What is the all time high TTM CAPEX for Pfizer?
- What is Pfizer TTM CAPEX year-on-year change?
What is Pfizer annual capital expenditures?
The current annual CAPEX of PFE is $3.91 B
What is the all time high annual CAPEX for Pfizer?
Pfizer all-time high annual capital expenditures is $3.91 B
What is Pfizer annual CAPEX year-on-year change?
Over the past year, PFE annual capital expenditures has changed by +$671.00 M (+20.74%)
What is Pfizer quarterly capital expenditures?
The current quarterly CAPEX of PFE is $651.00 M
What is the all time high quarterly CAPEX for Pfizer?
Pfizer all-time high quarterly capital expenditures is $1.14 B
What is Pfizer quarterly CAPEX year-on-year change?
Over the past year, PFE quarterly capital expenditures has changed by -$159.00 M (-19.63%)
What is Pfizer TTM capital expenditures?
The current TTM CAPEX of PFE is $3.04 B
What is the all time high TTM CAPEX for Pfizer?
Pfizer all-time high TTM capital expenditures is $3.91 B
What is Pfizer TTM CAPEX year-on-year change?
Over the past year, PFE TTM capital expenditures has changed by -$828.00 M (-21.43%)